3.An analysis of risk factors for mortality in patients with bloodstream infections caused by carbapenem-resistant Klebsiella pneumoniae
Qiuli ZHU ; Miaomiao GENG ; Ju WEI ; Yun SHEN ; Dan HU ; Chunxia CHEN ; Haiwei CHEN ; Zhe SUN
Shanghai Journal of Preventive Medicine 2025;37(4):296-300
		                        		
		                        			
		                        			ObjectiveTo explore the clinical characteristics and risk factors for 30-day mortality in hospitalized patients with bloodstream infections (BSI) caused by carbapenem-resistant Klebsiella pneumoniae (CRKP). MethodsData were obtained retrospectively from the electronic medical records of inpatients at a tertiary A-grade hospital in Shanghai from January 2016 to December 2023. The collected variables included age, gender, department, surgical treatment, empirical antibiotic therapy, Pitt Bacteremia score (PBS), Charlson comorbidity index (CCI), INCREMENT-CPE score (ICS), length of hospital stay, the time from CRKP-BSI to discharge and, etc. The follow-up period ended upon discharge, with the follow-up outcomes defined as in-hospital mortality or discharge. The endpoint was defined as death within 30 days (including day 30) caused by CRKP-BSI or infection-related complications. Patients who survived within 30 days after CRKP-BSI were classified into the survival group, while those who died within 30 days were classified into the death group. Independent risk factors for 30-day mortality in patients with CRKP-BSI were analyzed using univariate and multivariate Cox regression analysis. ResultsA total of 71 hospitalized patients with CRKP-BSI, comprising 51 males and 20 females, with an average age of (65.12±18.25) years, were included during the study period. The M (P25, P75) of hospital stay were 37.00 (24.00, 56.00) days, and M (P25, P75) of the duration from CRKP-BSI to discharge or death were 18.00 (7.00, 35.00) days. There were 20 deaths (28.17%) in the death group and 51 survivors (71.83%) in the survival group. The results of multivariate Cox regression analysis showed that the ICS as an independent risk factor for 30-day mortality in CRKP-BSI patients (HR=1.379, 95%CI: 1.137‒1.671, P=0.001). Each 1-point increase in the ICS was associated with a 37.9% increase in the risk of mortality. ConclusionThe ICS is found to be a risk factor for 30-day mortality in patients with CRKP-BSI, which may facilitate the prediction for the risk of 30-day mortality and thereby support clinical decision-making for patients with CRKP-BSI. 
		                        		
		                        		
		                        		
		                        	
5.Research progress on traditional Chinese medicine improving polycystic ovary syndrome by regulating NF-κB signaling pathway
Yi ZHANG ; Ping CHEN ; Yueliang WU ; Miaomiao XUE ; Jianhua SUN
China Pharmacy 2024;35(17):2181-2187
		                        		
		                        			
		                        			Polycystic ovary syndrome (PCOS) is a common endocrine disorder among women of childbearing age. Persistent chronic inflammation can promote the progression of PCOS, thereby causing serious impacts on women’s endocrine metabolism, reproductive function, and psychological status. Nuclear factors- κB (NF- κB) signaling pathway is one of the most classic inflammatory response transduction pathways and is closely related to the pathological process of PCOS. This article summarizes the mechanism of traditional Chinese medicine intervention in PCOS based on the NF-κB signaling pathway, and finds that various monomers of traditional Chinese medicine [flavonoids (naringenin, soy isoflavone, rhamnocitrin, etc.), alkaloids (berberine, ligustrazine) and terpenoids (artesunate, cryptotanshinone), glycosides (salidroside, glycyrrhizic acid)] and traditional Chinese medicine compounds [formula for tonifying kidney (Bushen huayu formula, Bushen huatan formula, etc.), formula for eliminating damp and dissolving phlegm (Cangfu daotan decoction, Xiehe yin, Erchen decoction), formula for regulating blood circulation and removing stasis (Gexia zhuyu decoction, Huatan tongmai yin)] can alleviate inflammatory response, improve abnormal glucose and lipid metabolism, and enhance ovarian function by inhibiting NF-κB signaling pathway, thus improving PCOS.
		                        		
		                        		
		                        		
		                        	
6.Analysis of 10 cases of brentuximab vedotin combined with chemotherapy in the treatment of children with refractory and or relapsed classic Hodgkin lymphoma
Nan LI ; Ying LI ; Chunju ZHOU ; Shuang HUANG ; Ling JIN ; Jing YANG ; Miaomiao SHAO ; Hao SUN ; Xiaoling WANG ; Yanlong DUAN
Chinese Journal of Pediatrics 2024;62(8):775-779
		                        		
		                        			
		                        			Objective:To evaluate the efficacy and safety of CD30 antibody-drug conjugates (ADC) brentuximab vedotin (BV) combined with chemotherapy in children with refractory or relapsed classic Hodgkin′s lymphoma (R/R cHL).Methods:Clinical data (including age, gender, B symptoms, clinical stage, previous treatment, etc.) of the 10 R/R cHL children diagnosed and treated at Beijing Children′s Hospital Affiliated to Capital Medical University from October 2021 to August 2023 were analyzed retrospectively. According to the different intensity of chemotherapy drugs, the dose of BV applied in the same course of treatment was 1.8 mg/kg for BV applied once every 3 weeks, and 1.2 mg/kg for BV applied once every 2 weeks. All 10 patients received at least 2 cycles of BV combined with chemotherapy and were evaluated every 2 cycles. The patients were followed up until May 31, 2024. The infusion reactions and adverse reactions after treatment were recorded.Results:In all 10 patients, there were 7 males and 3 females, the age ranged from 5.3-16.9 years, and there were 6 cases of refractory and 4 cases of relapsed. There were 6 cases of nodular sclerosis type, 2 cases of mixed cell type, 1 case of lymphocyte-rich type, and 1 case of lymphodepletion type. There were 5 cases of stage Ⅳ and 5 cases of stage Ⅲ. Previous treatment was mainly chemotherapy, 4 cases received radiotherapy and 1 case received programmed cell death protein 1 (PD-1) antibody therapy. The follow-up time ranged from 9 to 27 months. A total of 43 courses with 49 doses of BV alone or combined with chemotherapy were recorded, and the number of courses was 2 to 10 times. All 10 children responded to the treatment, and 9 achieved complete remission. BV infusion was successfully completed in all cases. A total of 28 cases of grade 3 or above adverse events were recorded, mainly myelosuppression, all of which were related to chemotherapy and did not affect sequential treatment.Conclusion:Brentuximab vedotin has demonstrated efficacy and a tolerable safety profile in the treatment of refractory and relapsed CD30-positive Hodgkin′s lymphoma in children.
		                        		
		                        		
		                        		
		                        	
7.Echocardiographic Diagnosis of Fetal Myocardial Non-Compaction
Lina WU ; Zhaoling ZHU ; Yuanyuan SUN ; Changhua WEI ; Miaomiao XIE ; Ruili WANG
Chinese Journal of Medical Imaging 2024;32(10):1042-1045
		                        		
		                        			
		                        			Purpose To explore the ultrasound features and early diagnostic clues of fetal myocardial non-compaction.Materials and Methods The clinical data and echocardiographic data of four fetuses who underwent fetal echocardiography in Henan Provincial People's Hospital from January 2015 to February 2023 and were confirmed to have myocardial non-compaction by pathological finding or postnatal examination were collected,and analyzed.Results A total of four fetuses diagnosed as myocardial non-compaction by prenatal ultrasound:two involved the left ventricle with isolated lesions,and apical myocardial non-compaction was confirmed by postnatal echocardiography;two involved the biventricles,and both of which were pathologically confirmed after induction of labor.The prenatal ultrasound of fetal myocardial involvement in four cases showed that:(1)the affected myocardium showed a bilayer structure:the outer layer was compacted myocardium,which showed thin and compacted homogeneous hypoechoic;the inner layer was loose and thickened non-compacted myocardium with enhanced echogenicity;(2)color Doppler flow imaging:the non-compacted myocardium showed sieve mesh blood flow with ventricular communication.Some cases were associated with cardiac enlargement and arrhythmia.Conclusion Prenatal echocardiography can diagnose fetal myocardial non-compaction with a characteristic echographic presentation.Localized myocardial thickening and echogenic enhancement,cardiac enlargement and arrhythmia may be important clues to identify fetal myocardial non-compaction.
		                        		
		                        		
		                        		
		                        	
8.Technical principle and cases analysis of faults of fully automatic ELISA analyzer
Weixin XU ; Miaomiao TAO ; Bo CAI ; Huiqin ZHANG ; Jie SUN
China Medical Equipment 2024;21(5):197-201
		                        		
		                        			
		                        			To study the technical principles and case analysis of typical fault of fully automatic enzyme-linked immunosorbent assay(ELISA)analyzer,in order to improve the usage effect of the analyzer.The microparticle enzyme immunoassay(MEIA)analysis technique was used to complete the ELISA test.The main calibration,standard calibration,qualitative calibration and calibration solution correction were used as the calibration methods of the ELISA analyzer to improve the analytic precision of ELISA.By analyzing the cases of typical faults encountered during the use of the fully automatic ELISA analyzer,such as washing machine,startup initialization alarm,boot disk,sampling arm and filter,the corresponding solutions of fault were proposed to provide reference for the maintenance and management of the fully automatic ELISA analyzer at later stage.
		                        		
		                        		
		                        		
		                        	
9.Effects of body mass index on nocturnal hypertension in patients with hypertension: a cross-sectional study
Wenqing WANG ; Zhihua LI ; Jing XUE ; Qian CUI ; Miaomiao SHANG ; Ping YIN ; Meijuan WANG ; Li GUO ; Dongmei SONG ; Guomei XU ; Dandan SUN ; Yuchuan DAI
Chinese Journal of Modern Nursing 2024;30(8):1090-1095
		                        		
		                        			
		                        			Objective:To explore the effects of body mass index (BMI) on the incidence of nocturnal hypertension in patients with hypertension.Methods:Totally 341 hospitalized hypertensive patients treated at the Affiliated Hospital of Jining Medical University from February to May 2023 were selected by convenience sampling. Patients' general information, clinical data, and 24-hour ambulatory blood pressure results were collected. A binomial Logistic regression analysis was conducted to investigate the factors affecting the occurrence of nocturnal hypertension in these patients. The relationship between BMI and the incidence of nocturnal hypertension was examined using threshold effect tests and smooth curve fitting.Results:The binomial Logistic regression analysis indicated that blood phosphate level was a factor influencing the occurrence of nocturnal hypertension in hypertensive patients ( P<0.05). Smooth curve fitting and threshold effect test results showed that the relationship between BMI and the incidence of nocturnal hypertension was curve-correlated, with a turning point at 24.61 kg/m 2. To the left of the turning point, there was no correlation ( P=0.130) ; to the right, there was a correlation ( P=0.016) . Conclusions:When the BMI of hypertensive patients exceeds 24.61 kg/m 2, the likelihood of nocturnal hypertension increases with rising BMI, providing a precise intervention target for weight management-based patient care in hypertension.
		                        		
		                        		
		                        		
		                        	
10.Correlation between monocyte/high-density lipoprotein cholesterol ratio and renal tubular injury and decreased renal function in patients with type 2 diabetes mellitus
Yue WANG ; Juan SUN ; Miaomiao HE
Chinese Journal of Diabetes 2024;32(9):662-666
		                        		
		                        			
		                        			Objective To investigate the correlation between monocyte/high-density lipoprotein cholesterol ratio(MHR)and renal tubule injury and decreased renal function in patients with type 2 diabetes mellitus(T2DM).Methods A total of 326 patients with T2DM who were hospitalized in The Department of Endocrinology,Affiliated Hospital of Xuzhou Medical University were enrolled in this study from September 2021 to March 2023.All the participants were divided into three groups according to urinary alpha1 microglobulin to creatinine ratio(MCR)and estimated glomerular filtration rate(eGFR):normal tubules with normal renal function(RTN+RFN,n=177),impaired tubules with normal renal function(RTI+RFN,n=100),and impaired tubules with decreased renal function(RTI+RFD,n=49).Results MHR was higher in RTI+RFD group than in RTN+RFN group and RTI+RFN group.MHR was higher in RTI+RFN group than in RTN+RFN group(P<0.05).Spearman correlation analysis showed that MHR was positively correlated with MCR and UACR(P<0.05),and negatively correlated with eGFR(P<0.05).Logistic regression analysiss showed that MHR and UACR were independent influencing factors for renal tubular injury in T2DM patients,and MHR,UACR and MCR were influential factors for renal function decline in T2DM patients(P<0.05).ROC curve analysis showed that the area under the curve of MHR was 0.794 and 0.779 in predicting tubular injury and renal function decline respectively in T2DM.Conclusions MHR is an influential factor for renal tubular injury and renal function decline.MHR is valuable in the diagnosis of rendl tubular injury and decreased renal function in T2DM patients.
		                        		
		                        		
		                        		
		                        	
            
Result Analysis
Print
Save
E-mail